Effect of Empagliflozin on Body Composition and Ketones
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate changes of body composition induced by
Sodium-glucose cotransporter-2 (SGLT2) inhibitor and its metabolic consequence in Korean type
2 diabetes (T2D).